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Ca21 signaling induced by sphingosylphosphorylcholine and
sphingosine 1-phosphate via distinct mechanisms in rat glomer-
ular mesangial cells.
Background. To elucidate the molecular mechanism underlying
sphingosine 1-phosphate (S1P) and sphingosylphosphorylcholine
(SPC) mediated signaling, we compared their effects with those of
adenosine triphosphate (ATP) and angiotensin II (Ang II) on the
cytosolic free Ca21 concentration ([Ca21]i), inositol 1,4,5-
trisphosphate (IP3) generation and arachidonic acid release in rat
glomerular mesangial cells.
Methods. The fluorescent Ca21 indicator, Fura-2, was used to
measure the [Ca21]i changes in cultured rat glomerular mesangial
cells either in suspension or attached to the coverslips.
Results. SPC 5 mM, S1P 5 mM, ATP 100 mM and Ang II 90 nM all
induced increases in the [Ca21]i, and the effect showed marked
homologous desensitization, while heterologous desensitization
was less. After the initial exposure of the cells to SPC, the increase
in [Ca21]i induced by subsequent addition of ATP or Ang II was
only reduced by about 14.3% and 4.8%, respectively. After the
initial exposure to S1P, a greater reduction was seen (42.1% and
47.7%, respectively). Both arachidonic acid release and IP3 gen-
eration were activated by all four agonists with an identical rank
order of effectiveness of SPC .. S1P . ATP 5 Ang II; both were
pertussis toxin-sensitive and cholera toxin-resistant. The arachi-
donic acid release induced by all four agonists showed identical
susceptibility to removal of extracellular Ca21, whereas IP3 gen-
eration displayed differential extracellular Ca21 dependence.
Only SPC-induced IP3 generation was highly sensitive to extracel-
lular Ca21 level, and this Ca21 dependence was abolished after
pretreatment of cells with arachidonyl trifluoromethyl ketone
(AACOCF3), a phospholipase A2 inhibitor. Furthermore, the
Mn21 influx was markedly greater in SPC-stimulated cells than in
either control or other agonist-stimulated cells, and was decreased
by prior exposure of cells to AACOCF3. After phospholipase A2
was inhibited or in the absence of extracellular Ca21, SPC
displayed identical effectiveness as S1P on desensitizing the action
of ATP or Ang II on the increase in [Ca21]i.
Conclusions. Our results indicate that all four agents primarily
activate phospholipase C through their receptor occupancies, but
that SPC alone also induces further significant Mn21 influx and
IP3 generation attributable to its primary stimulatory effect on
arachidonic acid release. Thus, the heterologous desensitization
to ATP or Ang II induced by SPC was less profound than that
induced by S1P, since SPC induced a Ca21 influx.
Elevation of the intracellular free Ca21 concentration
([Ca21]i) plays a pivotal role in the transduction of many
extracellular signals, including neurotransmitters, hor-
mones and cytokines [1]. Cells have evolved distinct mech-
anisms for the rapid and precise control of the Ca21
signaling process. Thus, both the extracellular Ca21 influx
and intracellular Ca21 release from non-mitochondrial
Ca21 pools contribute to the increase in [Ca21]i. In excit-
able cells, Ca21 influx through voltage-operated Ca21
channels represents the major Ca21 signal on membrane
depolarization [2]. In contrast, in nonexcitable cells, inosi-
tol 1,4,5-trisphosphate (IP3), generated by the activation of
phospholipase C following receptor binding, is responsible
for triggering the release of Ca21, while activation of
receptor-operated Ca21 channels is responsible for the
Ca21 influx [3–5]. In addition to IP3, several other com-
pounds have been identified which release Ca21 from the
intracellular Ca21 pools, including guanosine 59-triphos-
phate (GTP) [6], arachidonic acid [7], sphingosine [8],
cyclic adenosine 59-diphosphate (ADP) ribose [9] and
nicotinic acid adenine dinucleotide phosphate [10]. Fur-
thermore, activation of store-operated Ca21 channels
(SOC) increased the Ca21 permeability of the plasma
membrane after depletion of intracellular Ca21 pools by
second messengers [11], thus, replenishing the depleted
Ca21 pools and/or prolonging the intracellular Ca21 signal.
Recently, certain sphingolipid metabolites have been
implicated in many biological processes, including signal
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transduction pathways, cell growth, differentiation and
programmed cell death. Firstly, the dynamic balance be-
tween intracellular levels of ceramide and sphingosine
1-phosphate (S1P) determines the fate of the cell, with an
increase in intracellular ceramide levels stimulating the
stress-activated protein kinase and leading to apoptosis,
while S1P counteracts ceramide-induced cell death by
activating mitogen-activated protein kinase [12, 13]. Sec-
ondly, the mitogenic effect of platelet-derived growth fac-
tor (PDGF) is mediated by sphingolipid metabolites. In
Swiss 3T3 fibroblasts, S1P acts as the second messenger in
PDGF-induced cell proliferation [14]. Thirdly, exogenously
added S1P inhibits the PDGF-induced migration of human
arterial smooth muscle cells [15]. Fourthly, extracellular
sphingolipid metabolites themselves, such as sphingosine,
S1P and sphingosylphosphorylcholine (SPC), induces DNA
synthesis and cell proliferation [16]. Finally, in addition to
their mitogenic role, these sphingolipid metabolites also act
as extracellular signals and cause distinct cellular responses
via specific signaling pathways in various cell types. In
HL60 leukemia cells, SPC induces the production of super-
oxide anion and IP3, causing an increase in [Ca
21]i [17],
while in Swiss 3T3 fibroblasts it stimulates arachidonic acid
release [18]. S1P shares a common receptor with lysophos-
phatidic acid (LPA), the stimulation of which results in an
increase in [Ca21]i in platelets [19], whereas, in atrial
myocytes, it activates a muscarinic K1 current [20], and in
rat hepatocytes, it activates phospholipase C and inhibits
adenylyl cyclase via a receptor distinct from that for LPA
[21]. In Jurkat human leukemia cells and Swiss 3T3 fibro-
blasts [22, 23], sphingosine acts via phosphatidic acid
production, while in pancreatic acinar cells and human
foreskin fibroblasts it acts via SPC or S1P, respectively [24,
25].
Glomerular mesangial cells are believed to play an
important role in glomerular filtration rate regulation [26].
Several of the morphological and functional characteristics
of these cells are similar to those of vascular smooth muscle
cells [27], and a change in the [Ca21]i in the glomerular
mesangial cell may therefore be involved in the regulation
process. Many studies have shown that cross interactions
between distinct receptor signaling systems are involved in
modulating cellular functions. In the current study, we
characterized possible cross-interactions between sphingo-
lipid metabolites, ATP and angiotensin II (Ang II) in Ca21
signaling in glomerular mesangial cells, and found that SPC
and S1P activate an increase in [Ca21]i via distinct mecha-
nisms, with SPC not only triggering a Ca21 release via the
activation of phospholipase C, but also by stimulating
phospholipase A2-dependent Ca
21 influx, while S1P pre-
dominantly activates phospholipase C. The Ca21 influx
induced by SPC might explain why SPC is less effective




RPMI 1640 medium, fetal bovine serum, penicillin-
streptomycin, trypsin-EDTA and Hanks’ balanced salt so-
lution (HBSS) were purchased from Life Technologies,
Inc. (Grand Island, NY, USA). Fura-2 acetoxymethyl ester
was purchased from Molecular Probes (Eugene, OR,
USA). Collagenase type 1A-S, EGTA, insulin, digitonin,
ATP, Ang II, SPC, FITC-conjugated monoclonal anti-a-
smooth muscle actin and anti-cytokeratin peptide 18 anti-
bodies were obtained from Sigma (St. Louis, MO, USA).
Monoclonal mouse anti-human factor VIII-related antigen
and FITC-conjugated rabbit anti-mouse IgG were bought
from Dako (Glostrup, Denmark). Arachidonic acid, chol-
era toxin and pertussis toxin were obtained from Research
Biochemicals International (Natick, MA, USA). S1P and
bromoenol lactone were obtained from Biomol (Plymouth
Meeting, PA, USA) and arachidonyl trifluoromethyl ke-
tone (AACOCF3) from Calbiochem (San Diego, CA,
USA). [3H]arachidonic acid (180 to 240 Ci/mmol) was
purchased from New England Nuclear (Boston, MA, USA)
and the [3H]IP3 assay system from Amersham (Bucking-
hamshire, UK). All other chemicals were of analytical
grade and obtained from Merck (Darmstadt, Germany).
Culture of rat glomerular mesangial cells
Mesangial cells were prepared by the explant method as
described previously [28, 29]. Briefly, decapsulated renal
glomeruli from male Sprague-Dawley rats (150 to 200 g),
isolated by graded sieving using 60, 100 and 200 mesh
sieves, were collected from the top surface of the 200 mesh
sieve. After washing in HBSS, they were incubated with 0.5
mg/ml of collagenase type 1A-S in HBSS at 37°C for 40
minutes and mesangial cells obtained by plating in RPMI
1640 medium supplemented with 20% fetal bovine serum,
5 mg/ml insulin, 100 U/ml penicillin, 100 mg/ml streptomy-
cin and 10 mM HEPES, pH 7.4. On culturingat 37°C in an
atmosphere of 95% air/5% CO2, mesangial cells appeared
within 7 to 14 days and were confluent within 4 to 5 weeks.
The cells were subcultured by incubation with Ca21- and
Mg21-free 0.05% trypsin/EDTA solution and maintained
for five passages in culture. They were identified as mesan-
gial cells by positive immunocytochemical staining for
a-smooth muscle actin and negative staining for cytokera-
tin and factor VIII, markers for epithelial and endothelial
cells, respectively (data not shown). Where indicated, per-
tussis toxin or cholera toxin pretreatment of the cells was
performed by addition of 100 ng/ml of pertussis toxin or 1
mg/ml of cholera toxin to the medium 15 hours before
experiments.
Measurement of the [Ca21]i
Elevation of the [Ca21]i in mesangial cells was measured
fluorometrically as previously described [30]. Briefly, after
Chen et al: Cross-talk in Ca signaling in mesangial cells 1471
incubation with 5 mM fura-2 acetoxymethyl ester at 37°C for
30 minutes at a density of 1 3 106 cells/ml, the cells were
washed twice with loading buffer consisting of 150 mM
NaCl, 5 mM KCl, 2.2 mM CaCl2, 1 mM MgCl2, 5 mM glucose,
and 10 mM HEPES, pH 7.4 and were then suspended in the
same buffer. Changes in the emission fluorescence intensity
of fura-2 at 505 nm, with excitation wavelengths of 340 and
380 nm, were determined at room temperature using a
dual-wavelength fluorometer (SPEX, CM system). Some
experiments were performed using cells attached in a
coverslip. Coverslips were mounted in a modified Cunning-
ham chamber [31] attached to the stage of a Nikon Diaphot
inverted microscope, equipped with a Nikon 40x fluor
objective and a photomultiplier-based detection system
(Spex). Single cells were excited alternately with 340 nm
and 380 nm light, and the emitted fluorescent light was
collected by the objective through a 510 nm long-wave pass
filter. The [Ca21]i was calculated from the fluorescence
ratio, assuming a Kd of 135 nM for fura-2 and Ca21
equilibrium, as previously described in experiments using
suspension cells [32], while the fluorescence ratio obtained
at 340 and 380 nm (F340/F380) was used as an index of
[Ca21]i in experiments using attached cells. Some experi-
ments were performed in the absence of extracellular Ca21
by omitting Ca21 from the loading buffer. All experiments
were repeated at least five times using different batches of
cells. Results from one representative experiment are illus-
trated graphically and the mean 6 SD calculated from the
number (N) of experiments are shown.
Assay for arachidonic acid release
Confluent cells, grown in 24-well plates, were labeled
with [3H]arachidonic acid by adding 330 nCi/ml of
[3H]arachidonic acid and 0.01% bovine serum albumin
(BSA) to the growth medium. In some experiments, cells
were pretreated with either 100 ng/ml pertussis toxin or 1
mg/ml cholera toxin for 15 hours before [3H]arachidonic
acid labeling. After three hours at 37°C, unincorporated
[3H]arachidonic acid was thoroughly removed by four
washes, at 10 minute intervals, with loading buffer contain-
ing 0.1% BSA. The cells were then stimulated with various
agonists for the indicated time period in loading buffer,
with or without Ca21, and the radioactivity accumulated in
the medium (supernatant, S) or that remaining in the cells
(pellet, P) counted. [3H]arachidonic acid release was ex-
pressed as a percentage of total incorporated [3H]arachi-
donic acid, calculated as S/(P 1 S) 3 100. All experiments
were repeated at least five times, in triplicate, using differ-
ent batches of cells. The data presented are the mean 6 SD
calculated from N independent experiments.
Determination of IP3 generation
Cells were pretreated with either 100 ng/ml pertussis
toxin or 1 mg/ml cholera toxin for 15 hours or with the
phospholipase A2 inhibitor, AACOCF3 (3 mM), for three
minutes, then suspended in either Ca21-containing or
nominally Ca21-free loading buffer. The agonist-induced
IP3 generation within cells under these six different condi-
tions was quantified as previously described [30]. Briefly,
aliquots of cells (about 0.5 mg of cell protein) were
incubated with the indicated agonists at 37°C for 15 seconds
in a total volume of 100 ml of loading buffer, with or
without Ca21, and the amount of IP3 generated was
determined using the D-myo-[3H]IP3 radioreceptor assay
system (Amersham), following the manufacturer’s instruc-
tions. All experiments were performed at least five times in
triplicate using different batches of cells. The data, pre-
sented are the mean 6 SD from N independent experi-
ments, were analyzed using Student’s t-test.
Examination of fluorescence quenching by Mn21
Fura-2-loaded cells were suspended in loading buffer
containing 0.2 mM Ca21. At the indicated times, 1 mM
Mn21, either alone or plus SPC, S1P, ATP or Ang II, was
added and the Mn21 influx was monitored by quenching of
fura-2 fluorescence at the isosbestic wavelength, 360 nm. In
some experiments, cells were pre-incubated with 3 mM
AACOCF3 for three minutes before fluorescence quench-
ing was measured. All experiments were performed at least
five times, using different batches of cells. Results from one
representative experiment are illustrated graphically, while
the mean 6 SD for the fluorescence quenching during the
initial 20 seconds after Mn21 addition, calculated from the
number of experiments, are shown in Table 1 and were
analyzed by Student’s t-test.
RESULTS
Homologous and heterologous desensitization of [Ca21]i
increase induced by agonists in mesangial cells
Sphingolipid metabolites, including SPC and S1P, the
enzymic products of sphingomyeline deacylase and sphin-
gosine kinase, respectively, have been shown to act as
extracellular signals. Similarly, ATP and Ang II induce
Table 1. Effect of a phospholipase A2 inhibitor on SPC-, S1P-, ATP-
and Ang II-induced Mn21 influx in mesangial cells
Stimulus
Control cells AACOCF3-pretreated cells
Arbitrary unit cps 3 1025/20 seconds
None 2.4 6 0.20 2.3 6 0.24
SPC 5 mM 4.7 6 0.31a 2.4 6 0.21
S1P 5 mM 3.4 6 0.27a 2.4 6 0.25
ATP 100 mM 2.7 6 0.21b 2.4 6 0.20
Ang II 90 nM 2.6 6 0.20c 2.3 6 0.22
Control cells and cells pretreated with the phospholipase A2 inhibitor,
AACOCF3 (3 mM), were stimulated with the indicated agonists, and the
Mn21 influxes were monitored by measuring quenching of fura-2 fluores-
cence. The net decrease in fluorescence intensity during the initial 20
seconds after agonist addition was expressed in arbitrary units. The results
are the mean 6 SD (N 5 11), using different batches of cells. Abbrevia-
tions are in the Appendix.
a P , 0.0005 vs. unstimulated control cells
b P , 0.005 vs. unstimulated control cells
c P , 0.05 vs. unstimulated control cells
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distinct cellular events via activation of their specific recep-
tors in various cell types. In rat glomerular mesangial cells,
exogenously added SPC, S1P, ATP or Ang II all induced
increases in the [Ca21]i. As shown in Figure 1, in the
presence of extracellular Ca21, the [Ca21]i was increased
from the basal level of 60 6 9 nM (N 5 106) to peak levels
of 315 6 27 nM (N 5 31), 261 6 14 nM (N 5 21), 243 6 23
nM (N 5 18) or 214 6 17 nM (N 5 12) by the addition of 5
mM SPC, 5 mM S1P, 100 mM ATP or 90 nM Ang II,
respectively (traces a - d). Immediately after attaining the
peak level, the [Ca21]i declined to a new steady-state level
of 80 to 120 nM. Thus, the transient increase in [Ca21]i was
followed by a sustained plateau phase in all four Ca21
signaling pathways. Following the initial stimulation, a
second challenge with the same agonist during the sus-
tained phase did not result in any further significant [Ca21]i
increase (traces a - d). Thus, the Ca21 signaling pathways
evoked by SPC, S1P, ATP or Ang II in rat glomerular
mesangial cells displayed strict homologous desensitization.
In contrast, heterologous desensitization, demonstrated
by sequential addition of two different stimulants, was less
complete; the [Ca21]i increase in response to the second
stimulant was only partially inhibited. As shown in Figure 2,
after the initial exposure of cells to SPC, the peak increase
in [Ca21]i induced by subsequent ATP or Ang II addition
was reduced by 14.3 6 1.9% (N 5 16) and 4.8 6 0.4% (N 5
11), respectively, while a greater inhibition was seen after
initial exposure to S1P, the corresponding values being
42.1 6 4.9% (N 5 6) and 47.7 6 3.8% (N 5 6). If ATP was
added following Ang II stimulation or vice versa, similar
inhibition of the [Ca21]i responses was seen as using S1P
and ATP or Ang II (41.8 6 4.6%, N 5 12; 40.6 6 3.7%,
N 5 11, respectively). The statistical data for the changes in
the ATP- or Ang II-induced [Ca21]i are shown in Figure
2B. Similar results were observed in cells that were at-
tached to a coverslip, as shown in Figure 2C. On the basis
of the above data, it appears that S1P may induce Ca21
release from intracellular Ca21 pools bya mechanism sim-
ilar to that already well established for ATP or Ang II,
whereas SPC activates a Ca21 influx. This notion is further
supported by the results shown in Figure 3 in which cells
previously stimulated with ATP or Ang II showed a re-
duced response to subsequent addition of S1P (decrease of
34.6 6 3.7%, N 5 6 and 30.6 6 3.5%, N 5 6, respectively),
while the SPC response was less affected (16.1 6 1.8%, N 5
14 and 13.4 6 1.9%, N 5 10).
Agonists induced second messengers generation and
their sensitivities to toxins in glomerular mesangial cells
To elucidate the biochemical basis for the differential
effect of SPC and S1P on the ATP- and Ang II-induced
[Ca21]i increases, we measured potential second messenger
release and toxin susceptibilities to confirm that they act on
different G protein-coupled receptors. Since removal of
extracellular Ca21 reduced but did not block the SPC-,
S1P-, ATP- or Ang II-induced [Ca21]i increase (Fig. 8), it
seemed probable that a second messenger was generated
by these compounds as the linker between the cell surface
and intracellular Ca21 pools. To determine the effect of
Fig. 1. Homologous desensitization of the SPC-, S1P-, ATP- or Ang
II-induced [Ca21]i increase in rat glomerular mesangial cells. SPC 5 mM
(trace a), S1P 5 mM (trace b), ATP 100 mM (trace c) or Ang II 90 nM (trace
d) were added at the indicated time to fura-2-loaded mesangial cells.
Changes in [Ca21]i were measured in the presence of extracellular Ca
21.
The results shown are representative of 12 experiments. Abbreviations are
in the Appendix.
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SPC and S1P on the arachidonic acid release from cellular
lipids, cells were pre-loaded with [3H]arachidonic acid. In
the presence of extracellular Ca21, addition of SPC re-
sulted in a rapid marked increase in arachidonic acid
release (Fig. 4A). The release was time-dependent and was
not maximal by five minutes (Fig. 4A). Figure 4A further
shows that SPC was much more effective than S1P, ATP
and Ang II in activating phospholipase A2, the rank order
of effectiveness being 5 mM SPC .. 5 mM S1P . 100 mM
ATP 5 90 nM Ang II. The observed increases in arachi-
donic acid release may reflect a downstream event, rather
than a direct effect of receptor activaton. To determine
whether the enhanced arachidonic acid release was second-
ary to the influx of Ca21, the experiments were repeated in
the absence of extracellular Ca21. As shown in Figure 4B,
removal of extracellular Ca21 only slightly inhibited arachi-
donic acid release by about 15% in control cells and SPC-,
S1P-, ATP- and Ang II-stimulated cells, and it did not
change the rank order of effectiveness, indicating that the
arachidonic acid release induced by these four agonists
shows an identical susceptibility to removal of extracellular
Ca21, thus precluding the possibility that the activation of
phospholipase A2 induced by any of these compounds was
due to the primary Ca21 influx. To test the possibility of G
protein coupling, we also examined the effects of pertussis
toxin and cholera toxin on arachidonic acid release. The
enhanced arachidonic acid release induced by all stimulants
was completely inhibited by pretreatment of cells with 100
ng/ml of pertussis toxin for 15 hours (Fig. 4C), while
pretreatment with 1 mg/ml of cholera toxin for the same
time period did not alter their effectivenesses in stimulating
arachidonic acid release (Fig. 4D). Phospholipase A2 activ-
ity has previously been shown to be inhibited by a class of
arachidonic acid analogs [33]. To determine that arachi-
donic acid release was specifically due to the activation of
phospholipase A2, we pre-incubated mesangial cells for
three minutes with the analog, AACOCF3, before adding
the agonists. AACOCF3 (3 mM) totally blocked the arachi-
donic acid release induced by all four agonists (Fig. 4E).
In addition to inducing the arachidonic acid release,
SPC, S1P, ATP and Ang II also resulted in IP3 production,
the rank order of effectiveness being the same. The basal
level of IP3 of 1.45 6 0.07 pmol/mg (N 5 9) was increased
to 14.6 6 0.8 (N 5 9), 9.7 6 0.7 (N 5 9), 4.9 6 0.4 (N 5 9)
or 3.7 6 0.3 (N 5 9) pmol/mg following stimulation with
SPC, S1P, ATP or Ang II, respectively (Fig. 5A). These
results indicate that SPC is the most effective agonist in
Fig. 2. Heterologous desensitization of ATP- or Ang II-induced [Ca21]i
increases in glomerular mesangial cells. (A) Fura-2-loaded suspension
cells were initially exposed to 5 mM SPC (traces a and d), 5 mM S1P (traces
b and e), 90 nM Ang II (trace c) or 100 mM ATP (trace f). After 150
seconds, 100 mM ATP (traces a - c) or 90 nM Ang II (traces d - f) were
added, as indicated. The experiments were repeated a minimum of 6 times
with similar results. (B) The statistical data for the [Ca21]i changes
induced by ATP or Ang II are summarized. The maximal [Ca21]i increase
induced by initial exposure to 100 mM ATP or 90 nM Ang II (243 6 23 nM
(N 5 18) and 214 6 17 nM (N 5 12), respectively) were taken as 100%.
The data are the mean 6 SD of 6 to 16 independent experiments. (C)
Similar experiments were performed as in (A) using attached single cells.
[Ca21]i was expressed as the fluorescence ratio of 340 and 380 nm.
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stimulating IP3 generation (about 10-fold over basal levels)
and was also the only agonist affected by removal of
extracellular Ca21. As shown in Figure 5B, the SPC-
induced IP3 generation decreased by about 65% (P ,
0.001), while in control and S1P-, ATP- or Ang II-stimu-
lated cells the IP3 levels did not change significantly. These
results indicate that, following SPC stimulation, part of the
IP3 generation results from primary Ca
21 influx, which is
consistent with our previous notion that SPC may activate
Ca21 influx. Recently, arachidonic acid has been shown to
mobilize Ca21 by either activating Ca21 influx or triggering
Ca21 release [7, 34], and it was thus possible that the
marked sensitivity of SPC to extracellular Ca21 levels in
terms of IP3 generation may have resulted from its effec-
tiveness in arachidonic acid release. We therefore exam-
ined the effect of inhibiting phospholipase A2 on IP3
generation. To confirm that the IP3 generation was partially
due to phospholipase A2 activation, we pre-incubated
mesangial cells for three minutes with AACOCF3 (3 mM),
which totally blocked the arachidonic acid release (Fig.
4E), before adding the agonists. As shown in Figure 5C, the
SPC-induced stimulation of IP3 generation was significantly
inhibited by AACOCF3 (P , 0.001), while the effects of the
other agonists were not significantly altered. Furthermore,
in the presence of the phospholipase A2 inhibitor, the
dependence of the SPC-induced IP3 generation on extra-
cellular Ca21 was abolished. Thus, after prior exposure of
cells to phospholipase A2 inhibitor, the degree of IP3
generation induced by all four agonists in the absence of
extracellular Ca21 (Fig. 5D) was virtually identical to those
measured in the presence of extracellular Ca21 (Fig. 5C).
The effects of pertussis toxin and cholera toxin on receptor
activation-mediated IP3 generation are shown in Figure 5 E
and F, respectively. Stimulation of IP3 generation was
completely inhibited after pertussis toxin pretreatment,
while cholera toxin had no effect, regardless of the type of
receptor activation. Thus, these agonists showed similar
toxin sensitivities in terms of activation of phospholipase A2
(Fig. 4) and phospholipase C (Fig. 5).
Mn21 influx stimulated by agonists-induced arachidonic
acid release
The results described above indicate that SPC-induced
IP3 generation is partially dependent on extracellular Ca
21
and occurs in parallel with the activation of phospholipase
A2. The questions we next addressed were whether SPC
induces Ca21 influx and if so, whether it is sensitive to the
phospholipase A2 inhibitor. If SPC does induce Ca
21 influx,
Fig. 3. Effect of initial exposure to ATP or Ang II on the subsequent SPC-
or S1P-induced [Ca21]i increase in glomerular mesangial cells. (A) SPC
(5 mM) (traces a and b) or S1P (5 mM) (traces c and d) was added, as
indicated, in the presence of extracellular Ca21, after initial exposure of
the cells to ATP (100 mM) (traces a and c) or Ang II (90 nM) (traces b and
d). (B) The statistical data for the [Ca21]i changes induced by SPC or S1P
are summarized. The maximal [Ca21]i increase induced by an initial
exposure to 5 mM SPC or 5 mM S1P (315 6 27 nM (N 5 31) and 261 6 14
nM (N 5 21), respectively) was taken as 100%. The data are the mean 6
SD of 6 to 14 independent experiments.
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it would not deplete the Ca21 pools to the same extent as
S1P and, consequently, the cross desensitization of ATP
and Ang II by SPC in terms of the [Ca21]i increase would
be expected to be less than by S1P. Mn21 presumably
enters cells via the same pathways as Ca21 and has been
used as a substitute for Ca21 in studies of Ca21 influx. Once
Mn21 accumulates in the cytosol, it cannot be transported
by Ca21 pumps or accumulated in intracellular Ca21 stores.
Thus, the extent of fluorescence quenching at the isosbestic
point for fura-2 fluorescence provides an estimate of the
unidirectional Ca21 entry. As shown in Figure 6, in non-
pretreated cells, the fluorescence quench induced by SPC
was significantly greater (P , 0.0005) than that induced by
S1P (P , 0.0005), ATP (P , 0.005) or Ang II (P , 0.05)
when compared with that of the control cells (traces a - e).
However, after pretreatment of cells with AACOCF3, the
fluorescence quench induced by SPC, S1P, ATP or Ang II
was indistinguishable from that in control Mn21-treated
cells (traces f - j). The statistical data are summarized in
Table 1.
These results indicate that SPC-induced Mn21 influx is
completely abolished by pretreatment of cells with a phos-
pholipase A2 inhibitor. We then determined whether ara-
chidonic acid, the product of phospholipase A2 action,
causes Ca21 influx in mesangial cells. As shown in Figure 7,
a [Ca21]i increase was seen in response to addition of 10 mM
arachidonic acid both in the presence (trace a) or absence
(trace b) of extracellular Ca21, the mean [Ca21]i changes
(peak [Ca21]i minus baseline values) being 234 6 20 nM
(N 5 8) and 164 6 14 nM (N 5 8), respectively. In contrast
to the receptor agonist-induced [Ca21]i increase (Figs. 1
and 2), there was a 15 to 20 second latency before the onset
of the arachidonic acid-induced [Ca21]i increase.
Role of phospholipase A2-dependent-Ca
21 influx on
heterologous desensitization
Our results indicate that the phospholipase A2-depen-
dent Ca21 influx might be responsible for the markedly
reduced heterologous desensitization of the [Ca21]i in-
crease observed after treatment of mesangial cells with
SPC. We next assessed the effect of ATP or Ang II on
[Ca21]i increase in SPC- or S1P-stimulated cells in the
absence of extracellular Ca21 or in the presence of AA-
COCF3 to eliminate the SPC-induced Ca
21 influx. As
shown in Figure 8A, in nominally Ca21-free medium, the
[Ca21]i increase induced by 5 mM SPC, 5 mM S1P, 100 mM
ATP or 90 nM Ang II was 127 6 11 nM, 172 6 14 nM, 60 6
5 nM and 75 6 7 nM (N 5 10), respectively. A subsequent
challenge with ATP or Ang II in SPC-stimulated cells
caused a reduced [Ca21]i increase by about 63% and 56%,
respectively (traces a and e). A similar cross desensitization
between initial S1P stimulation and subsequent challenge
with ATP or Ang II was demonstrated in traces b and f; the
[Ca21]i response decreased approximately 58% and 40%,
respectively. Thus, SPC and S1P display similar potency to
desensitize the action of ATP or Ang II in the absence of
extracellular Ca21. This is further supported by results
shown in traces c, d, g and h in which cells previously
stimulated with ATP or Ang II showed a similar reduced
response to subsequent addition of SPC (53% and 58%,
respectively) or S1P (63% and 59%, respectively). Similar
extents of cross desensitization caused by SPC or S1P to
ATP or Ang II were seen in cells that had been exposed to
AACOCF3 for three minutes (Fig. 8B). Thus, the blockade
of SPC-induced Ca21 influx by either removal of the
Fig. 4. Effect of extracellular Ca21 and toxin
pretreatment on agonist-induced arachidonic
acid release in mesangial cells. Prelabeled
mesangial cells were stimulated with buffer (F),
90 nM Ang II (), 100 mM ATP (), 5 mM S1P
(f) or 5 mM SPC (M) in normal Ca21-
containing (A) or nominally Ca21-free (B)
extracellular solution. The release of
radioactivity into the extracellular solution was
assayed at different time. Similar experiments
were performed using cells pretreated with 100
ng/ml pertussis toxin (C), 1 mg/ml cholera toxin
(D) or 3 mM AACOCF3 for 15 hours, 15 hours
or three minutes, respectively. The results are
expressed as the percentage of total
radioactivity incorporated into the cells
subtraction the basal value at t 5 0. The data
are the mean 6 SD of 5 to 9 independent
experiments.
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extracellular Ca21 or inclusion of AACOCF3, the heterol-
ogous desensitization to ATP or Ang II in [Ca21]i increase
induced by SPC was identical to that induced by S1P (Fig.
9). These data support the view that SPC-induced phos-
pholipase A2-dependent Ca
21 influx attenuates the heter-
ologous desensitization to ATP or Ang II.
The remaining responses of the [Ca21]i increase to
agonist stimulations following the pretreatment of cells
with AACOCF3 or in the absence of extracellular Ca
21
(Fig. 8) were predominantly due to the agonist-induced IP3
generation, since the magnitudes only slightly decreased
after cells were treated with bromoenol lactone, a Ca21-
independent phospholipase A2 inhibitor, and AACOCF3
simultaneously, suggesting that this part of [Ca21]i increase
was independent to the activity of phospholipase A2 (Fig.
10).
Our data also show that phospholipase A2-dependent
Ca21 influx induced by SPC further stimulates the genera-
tion of IP3 (Fig. 5). Since SPC-stimulated arachidonic acid
release procedes at least over five minutes (Fig. 4), one
would expect that the time kinetic of SPC-induced IP3
generation occurs in a parallel mode. In fact, as shown in
Figure 11A, IP3 generation reached the peak at 15 seconds,
and thereafter it rapidly declined almost to the basal level
within one minute regardless of the stimulation of cells with
SPC, S1P, ATP or Ang II. Inhibition of phospholipase A2
by AACOCF3 markedly decelerated the SPC-induced IP3
generation, the peak of IP3 generation occurred at 30
seconds (Fig. 11B), while it barely had an effect on S1P-,
ATP- or Ang II-induced IP3 generation. In addition, the
decline of IP3 generation remained the same in the pres-
ence of AACOCF3. As shown in Figure 11C, in AACOCF3-
treated cells, an addition of 10 mM arachidonic acid caused
an increase of IP3 generation with a 15 second latency, the
Fig. 5. Effect of extracellular Ca21,
phospholipase A2 inhibitor, pertussis toxin or
cholera toxin on agonist-induced IP3 generation
in mesangial cells. IP3 generation was
measured in control cells (A) or cells pretreated
with 3 mM AACOCF3 for three minutes (C and
D) or 100 ng/ml pertussis toxin (E) or 1 mg/ml
cholera toxin (F) for 15 hours. Aliquots of cells
(0.5 mg of cell protein) were stimulated with
buffer, 5 mM SPC, 5 mM S1P, 100 mM ATP and
90 nM Ang II at 37°C for 15 seconds. In some
experiments, extracellular Ca21 was removed (B
and D). IP3 was then extracted and determined
using a radioreceptor assay. The data are the
mean 6 SD values of 5 to 7 independent
experiments. An asterisk represents P , 0.001.
The number sign (E) indicates a significant
decrease in IP3 generation after pertussis toxin
pretreatment (P , 0.001).
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peak level occurring at 30 seconds. An additive effect of IP3
generation was observed when arachidonic acid was added
simultaneously with SPC, S1P, ATP or Ang II in AA-
COCF3-treated cells (Fig. 11 B, C). Thus, an addition of
arachidonic acid to AACOCF3-treated cells partially re-
versed the inhibitory effect of AACOCF3 on SPC-induced
IP3 generation. These results suggest that the SPC-induced
arachidonic acid release further potentiated IP3 generation,
but that a sustained IP3 generation did not occur in parallel
with arachidonic acid release.
DISCUSSION
Sphingolipid metabolites have recently been shown to
affect a wide variety of biological processes in several cell
types. In the current study, in rat glomerular mesangial
cells, phospholipase A2 was shown to play a role in SPC-
induced Ca21 influx in an intact cellular system. In addi-
tion, the arachidonic acid-induced Ca21 influx resulted in
an IP3 generation over and above that caused by primary
activation of phospholipase C on SPC stimulation. Apart
from inducing a Ca21 influx, arachidonic acid also triggers
the Ca21 release from intracellular Ca21 pools, although
the identity of the pools is uncertain. The S1P signaling
mechanism was simpler, stimulating phospholipase C via a
pertussis toxin-sensitive G protein. Based on the above
results, it appears that SPC and S1P differentially regulate
the Ca21 signaling pathway, with S1P inducing a [Ca21]i
increase predominantly by the Ca21 release from intracel-
lular IP3-sensitive Ca
21 pools, while SPC also induces a
Ca21 influx.
The reason why SPC has a less potent desensitization
effect than S1P on the action of ATP or Ang II may be
related to the ability of SPC to stimulate Ca21 influx. It is
possible that the Ca21 that entered the cells after exposure
to SPC is used to fill the intracellular Ca21 pools, and that
the availability of Ca21 within the intracellular Ca21 pools
is a critical consequence of SPC pretreatment. Indeed, we
have previously shown, in NG108-15 cells, that a shared
intracellular Ca21 pool is sensitive to opioid, bradykinin
and P2-purinoceptor agonists; however, a defined pool of
phosphatidylinositol 4,5-bisphosphate or a specific phos-
pholipase C is responsible for the action of each receptor
[30]. Thus, in the presence of extracellular Ca21, although
Fig. 6. Effect of preincubation of cells with
phospholipase A2 inhibitor on agonist-induced
Mn21 influx. After preincubation with (traces f
- j), or without, 3 mM AACOCF3 (traces a - e)
for three minutes, fura-2-loaded mesangial cells
were suspended in loading buffer containing 0.2
mM Ca21, then 1 mM Mn21 (Mn), 1 mM Mn21
plus 5 mM SPC (Mn 1 SPC), 1 mM Mn21 plus
5 mM S1P (Mn 1 S1P), 1 mM Mn21 plus 100
mM ATP (Mn 1 ATP) or 1 mM Mn21 plus 90
nM Ang II (Mn 1 Ang II) was added and the
fluorescence quench due to Mn21 influx was
measured. The experiment was repeated 11
times with similar results; one representative
result is shown.
Fig. 7. Arachidonic acid-induced [Ca21]i increase in mesangial cells.
Fura-2-loaded cells were suspended in either normal Ca21-containing
(trace a) or nominally Ca21-free (trace b) loading buffer and [Ca21]i
changes were monitored in response to the addition of 10 mM arachidonic
acid, as indicated by arrowheads. The experiment was repeated 8 times,
using different batches of cells, with similar results. One representative
result is shown.
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Fig. 8. Effect of phospholipase A2-dependent
Ca21 influx on heterologous desensitization of
[Ca21]i increases induced by SPC, S1P, ATP or
Ang II in mesangial cells. (A) In nominally Ca21-
free buffer, fura-2-loaded cells were initially
exposed to 5 mM SPC (traces a and e), 5 mM S1P
(traces b and f), 100 mM ATP (traces c and d) or
90 nM Ang II (trace g and h). After 90 seconds,
100 mM ATP (traces a and b), 90 nM Ang II
(traces e and f), 5 mM SPC (traces c and g) or 5
mM S1P (traces d and h) was added, as indicated.
(B) Similar experiments were performed as in
(A) excepted that cells had been exposed to 3 mM
AACOCF3 for three minutes and cells were
suspended in normal Ca21 containing buffer
prior to the experiment. The experiments were
repeated a minimum of 6 times with similar
results.
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SPC can generate significant amounts of IP3, the intracel-
lular Ca21 pools would not be depleted since Ca21 influx
occurs simultaneously.
SPC (lysosphingomyelin) is structurally similar to deter-
gents and it is possible that the observed effects on
Ca21/Mn21 influx might be due to a general increase in cell
permeability. However, the results of the pertussis toxin
sensitivity experiments and the blockade by AACOCF3
preclude this possibility. SPC displays an identical effective-
ness as S1P on desensitizing the action of ATP or Ang II on
[Ca21]i increase if the SPC-induced Ca
21 influx is blocked
by removal of extracellular Ca21. Similar results are seen
when phospholipase A2 is inhibited in the presence of
extracellular Ca21 (Fig. 8). These results suggest that
SPC-induced Ca21 influx is dependent on the arachidonic
acid release. Furthermore, the concentration of SPC used
in the current study (5 mM) is much lower than that (300
mM) required to increase the general permeability of the
plasma membrane in NG108-15 cells [35].
Our data indicate that arachidonic acid-induced Ca21
influx further potentiates the IP3 generation in SPC-stim-
ulated cells, but that the time kinetic of SPC-induced IP3
generation does not occur in parallel with the arachidonic
acid release. SPC-stimulated arachidonic acid release or
SPC-induced Mn21 influx proceeds at least over 3 to 5
minutes (Figs. 4 and 6), while the SPC-induced IP3 gener-
ation returns to the basal level within 90 seconds (Fig. 11).
It is possible that the pool of phosphatidylinositol 4,5-
bisphosphate may be limited or the degradation of IP3 is
accelerated once the increase of [Ca21]i reaches a certain
extent. Indeed, the time kinetic of IP3 generation parallels
the [Ca21]i increase induced by SPC. Nevertheless, the
results in Figure 11 further confirm the view that part of the
IP3 generation induced by SPC is due to the action of
arachidonic acid. Re-addition of arachidonic acid to AA-
COCF3-treated cells partially reverses the inhibitory effect
of AACOCF3 on SPC-induced IP3 generation.
Using permeabilized DDT1MF-2 smooth muscle cells,
Ghosh, Bian and Gill first showed that sphingosine and
SPC induce a Ca21 release from intracellular Ca21 stores
[8]. Thus, SPC may act as a further intracellular Ca21
release mediator, in addition to IP3, ryanodine (caffeine),
GTP, cyclic ADP ribose, nicotinic acid adenine dinucle-
otide phosphate and arachidonic acid. Recently, a cDNA
Fig. 9. [Ca21]i changes induced by SPC, S1P,
ATP or Ang II measured while phospholipase
A2-dependent Ca
21 influx is blocked. The
statistical data observed in Figure 8 are
summarized. The data are the mean 6 SD of 10
independent experiments.
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clone (1,869 nt), encoding a sphingolipid-gated Ca21 per-
meable channel in the endoplasmic reticulum, has been
identified and named SCaMPER (sphingolipid Ca21 re-
lease-mediating protein of endoplasmic reticulum) [36]. On
the basis of its mRNA size and the number of transmem-
brane domains in its molecular structure, SCaMPER is
distinct from the IP3 and ryanodine receptor. The mRNA
for SCaMPER (1.8 kb) is much smaller than those for the
IP3 receptor (9 kb) [37] and ryanodine receptor (16 kb) [38]
and contains two potential transmembrane domains, while
the IP3 and ryanodine receptor molecules have six and four,
respectively. SCaMPER has an EC50 of 40 mM for SPC,
similar to the value obtained using a microsomal fraction to
measure the affinity of SPC in Ca21 release (20 to 75 mM)
[8, 35, 39, 40]. The discrepancy between the concentrations
required for SPC to exert its function intracellularly or
extracellularly suggest dual roles for SPC, which acts as an
extracellular signal, as in the present study, or as a second
messenger to transduce an extracellular signal.
Our data suggest that in addition to inducing Ca21 influx,
the arachidonic acid triggers Ca21 release from intracellu-
lar Ca21 pools. Firstly, both Ca21 influx and Ca21 release
were seen in response to the addition of arachidonic acid
(Fig. 7). Secondly, in the absence of extracellular Ca21,
SPC-induced IP3 generation was not distinguishable from
those induced by ATP or Ang II (Fig. 5), while the [Ca21]i
increase induced by SPC was higher than those induced by
ATP or Ang II since SPC induced arachidonic acid release
(Fig. 9). Using a membrane preparation of the rat cerebel-
lum, we have previously shown that mitochondria are more
sensitive than microsomes to the arachidonic acid-induced
release of accumulated Ca21 [35]. Thus, the SPC-evoked
[Ca21]i increase is partly due to arachidonic acid-induced
Ca21 release. Our results demonstrate a role for arachi-
donic acid in mediating Ca21 release in an intact cellular
system.
Depletion of intracellular Ca21 pools may transduce a
signal to the plasma membrane to increase the Ca21
permeability, so-called capacitative Ca21 entry [41]. In rat
glomerular mesangial cells, the depletion of IP3-sensitive
Ca21 stores appears insufficient to alter the permeability of
the plasma membrane to Ca21, as the fluorescence quench
induced by Mn21 influx was indistinguishable between
control and all agonist-stimulated cells following AA-
COCF3 pretreatment to prevent the generation of arachi-
donic acid (Fig. 6 and Table 1). The phospholipase A2
inhibitor had no effect on S1P-induced IP3 generation,
while it totally blocked S1P-induced Mn21 influx (Figs. 5
and 6). Thus, in rat glomerular mesangial cells, Mn21 influx
closely correlates with arachidonic acid release, but not
with IP3 generation, and represents an arachidonic acid-
induced Ca21 influx.
Our data demonstrate that part of the SPC-induced IP3
generation was dependent on extracellular Ca21 and part
dependent on the release of arachidonic acid (Figs. 5B, 5C
and 11). These two IP3 fractions seem to overlap. In the
presence of AACOCF3, the Ca
21-dependent fraction is lost
(Fig. 5 C, D), while the AACOCF3-dependent fraction is
not seen in the absence of extracellular Ca21 (Fig. 5 B, D).
These results support the view that part of the SPC-induced
IP3 generation is attributable to its primary stimulatory
effect on arachidonic acid release, which is responsible for
the Ca21 influx and part of the IP3 generation is via the
direct coupling of phospholipase C activation, the resulting
[Ca21]i increase is independent to the inhibition of phos-
pholipase A2 (Fig. 10).
Our results indicate that SPC and S1P induce the [Ca21]i
increase via distinct mechanisms, suggesting that they act
through their own receptors. Recently, the gene product of
edg-1 has been clearly identified as the receptor for S1P,
while that of edg-2/vzg-1/rec1.3 is for LPA [42, 43]. These
two genes display 37% homology and are members of a
common orphan receptor subfamily. In contrast, the evi-
dence in support of the receptor for SPC is limited,
although products of other members (edg-3 and H218)
have been identified to be the receptors for S1P and/or SPC
[44]. Whether SPC acts through the same receptor as S1P
needs further study. S1P is synthesized by the sequential
enzymatic reactions of sphingomyelinase, ceramidase and
sphingosine kinase, while the evidence in support of SPC
Fig. 10. Effect of AACOCF3 and bromoenol lactone on SPC- and S1P-
induced [Ca21]i increase. After initial exposure cells to 3 mM AACOCF3
and 10 mM bromoenol lactone (AACOCF3 1 HELSS), 5 mM SPC (traces
a and c), 5 mM S1P (traces b and d), 100 mM ATP (traces a and b) or 90
nM Ang II (traces c and d) were added as indicated. The experiments were
repeated 8 times with similar results; one representative result is shown.
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being a naturally occurring product is limited since the
existence of sphingomyelin deacylase in eukaryotes needs
to be identified. Thus, the physiological role of S1P as an
extracellular or intracellular signaling molecule is better
established than that of SPC in terms of their occurrence
and identified receptors.
In conclusion, the result presented in this study provide
evidence in support of a role for arachidonic acid in
mediating Ca21 influx in an intact cellular system. In rat
glomerular mesangial cells, SPC stimulates phospholipases
C and A2 to generate IP3 and arachidonic acid, respectively.
The SPC-induced arachidonic acid release subsequently
triggers the Ca21 influx, which in turn further activates
phospholipase C. In contrast, S1P induces a [Ca21]i inrease
predominantly via stimulation of phospholipase C. Thus,
the Ca21 signaling mechanisms induced by SPC and S1P
are distinct. S1P is a more potent desensitizer than SPC on
the effect of ATP or Ang II on the [Ca21]i increase, as SPC
induces a Ca21 influx.
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